Arbutus Biopharma
ABUS
ABUS
48 hedge funds and large institutions have $100M invested in Arbutus Biopharma in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Holders
48
Holding in Top 10
–
Calls
$11.6M
Puts
$19.1M
Top Buyers
| 1 | +$8.83M | |
| 2 | +$4.56M | |
| 3 | +$3.75M | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$2.11M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$2.05M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$15.7M | |
| 3 | -$9.23M | |
| 4 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$6.25M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.13M |